Paper37048331
Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections.
Ekiz E and 10 others. Foods, 2023. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections. Papers, record 37048331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37048331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34347990 | Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review. | Int J Med Mushrooms | 2021 | https://conductscience.org/library/papers/34347990 | PubMed |
| 2 | 35078094 | Icariin and its metabolites as potential protective phytochemicals against cardiovascular disease: From effects to molecular mechanisms. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35078094 | PubMed |
| 3 | 25790910 | Anti-diabetic effects of Ganoderma lucidum. | Phytochemistry | 2015 | https://conductscience.org/library/papers/25790910 | PubMed |
| 4 | 33290972 | In silico screening of potential anti-COVID-19 bioactive natural constituents from food sources by molecular docking. | Nutrition | 2021 | https://conductscience.org/library/papers/33290972 | PubMed |
| 5 | 35407117 | Nutritional Profile and Health Benefits of Ganoderma lucidum "Lingzhi, Reishi, or Mannentake" as Functional Foods: Current Scenario and Future Perspectives. | Foods | 2022 | https://conductscience.org/library/papers/35407117 | PubMed |
| 6 | 35125518 | Food nutrients as inherent sources of immunomodulation during COVID-19 pandemic. | Lebensm Wiss Technol | 2022 | https://conductscience.org/library/papers/35125518 | PubMed |
| 7 | 34736135 | Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe. | Bioorg Chem | 2021 | https://conductscience.org/library/papers/34736135 | PubMed |
| 8 | 29528772 | Functional Food and Cardiovascular Disease Prevention and Treatment: A Review. | J Am Coll Nutr | 2018 | https://conductscience.org/library/papers/29528772 | PubMed |
| 9 | 33942057 | Ultra-processed Foods and Cardiovascular Diseases: Potential Mechanisms of Action. | Adv Nutr | 2021 | https://conductscience.org/library/papers/33942057 | PubMed |
| 10 | 32226288 | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. | Int J Biol Sci | 2020 | https://conductscience.org/library/papers/32226288 | PubMed |
| 11 | 30114634 | Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/30114634 | PubMed |
| 12 | 16905165 | Ganoderma - a therapeutic fungal biofactory. | Phytochemistry | 2006 | https://conductscience.org/library/papers/16905165 | PubMed |
| 13 | 32714204 | Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. | Front Physiol | 2020 | https://conductscience.org/library/papers/32714204 | PubMed |
| 14 | 27438015 | Hypocholesterolemic Properties and Prebiotic Effects of Mexican Ganoderma lucidum in C57BL/6 Mice. | PLoS One | 2016 | https://conductscience.org/library/papers/27438015 | PubMed |
| 15 | 36068771 | Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/36068771 | PubMed |
| 16 | 28052025 | Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships. | Oncotarget | 2017 | https://conductscience.org/library/papers/28052025 | PubMed |
| 17 | 33574978 | Antioxidant Food Components for the Prevention and Treatment of Cardiovascular Diseases: Effects, Mechanisms, and Clinical Studies. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/33574978 | PubMed |
| 18 | 34478790 | Purification and comparative study of bioactivities of a natural selenized polysaccharide from Ganoderma Lucidum mycelia. | Int J Biol Macromol | 2021 | https://conductscience.org/library/papers/34478790 | PubMed |
| 19 | 35576662 | Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35576662 | PubMed |
| 20 | 28760544 | The potential of Ganoderma lucidum extracts as bioactive ingredients in topical formulations, beyond its nutritional benefits. | Food Chem Toxicol | 2017 | https://conductscience.org/library/papers/28760544 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42651796 | Dietary Ganoderma lucidum Modulates Liver and Adipose Tissue Responses in Western Diet-Fed C57BL/6J Mice. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42651796 | PubMed |
| 42510648 | Bioactivity Research in Ganoderma lucidum: A Scientometric Analysis of Global Trends, Translational Gaps, and Emerging Research Frontiers. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510648 | PubMed |
| 42280437 | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation. | Nutrients | 2026 | https://conductscience.org/library/papers/42280437 | PubMed |
| 42188043 | Ganoderma lucidum as a Functional Bioactive Candidate for Glycemic Regulation: Mechanisms, Preclinical Evidence, and Clinical Translation. | Metabolites | 2026 | https://conductscience.org/library/papers/42188043 | PubMed |
| 41754188 | Edible Bird's Nest as a Multi-Component Functional Food for Brain Aging: From Single-Bioactive Actions to Network-Regulatory Mechanisms. | Nutrients | 2026 | https://conductscience.org/library/papers/41754188 | PubMed |
| 41566790 | Fermented Moringa oleifera leaves and Ganoderma lucidum mixtures ameliorate cognitive deficits in scopolamine-induced dementia rats by enhancing brain antioxidant and cholinergic functions. | Pharm Biol | 2026 | https://conductscience.org/library/papers/41566790 | PubMed |
| 41445832 | From functional foods to immunotherapeutic agents: mechanistic insights into medicinal mushroom bioactives in chronic inflammation management. | Front Nutr | 2025 | https://conductscience.org/library/papers/41445832 | PubMed |
| 41342967 | Bioactive compounds of Ganoderma species: molecular mechanisms and therapeutic potential in cancer and metabolic disorders. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41342967 | PubMed |
| 41150791 | Immunomodulatory Effects of Ganoderma lucidum Bioactive Compounds on Gut-Brain and Gut-Liver Axis Disorders. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150791 | PubMed |
| 40942174 | From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications. | Molecules | 2025 | https://conductscience.org/library/papers/40942174 | PubMed |
| 40864778 | Evaluation of Bioactive Compounds, Antioxidant Activity, and Anticancer Potential of Wild Ganoderma lucidum Extracts from High-Altitude Regions of Nepal. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40864778 | PubMed |
| 40855247 | Phytochemical analysis and antimicrobial activity of Ganoderma lucidum against selected bacteria and fungi of medical importance. | Sci Rep | 2025 | https://conductscience.org/library/papers/40855247 | PubMed |
| 40662561 | A Mini-review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions. | Cent Nerv Syst Agents Med Chem | 2026 | https://conductscience.org/library/papers/40662561 | PubMed |
| 40661810 | A Review of Bioactive Components and Pharmacological Effects of Ganoderma lucidum. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40661810 | PubMed |
| 40487785 | Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40487785 | PubMed |
| 40362877 | Supporting Neurologic Health with Mushroom Nutrition. | Nutrients | 2025 | https://conductscience.org/library/papers/40362877 | PubMed |
| 40284417 | Unlocking the Potential of Ganoderma lucidum (Curtis): Botanical Overview, Therapeutic Applications, and Nanotechnological Advances. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284417 | PubMed |
| 40178632 | Elucidation of Foraging Strategies of Ganoderma lucidum and Ganoderma neo-japonicum on Different Nutrients Composition Using Fractal Morphology. | Curr Microbiol | 2025 | https://conductscience.org/library/papers/40178632 | PubMed |
| 39840400 | Integrating transcriptomics, metabolomics, and network pharmacology to investigate multi-target effects of sporoderm-broken spores of Ganoderma lucidum on improving HFD-induced diabetic nephropathy rats. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39840400 | PubMed |
| 39766499 | In Vitro Antimicrobial Efficacy Assessment of Ethanolic, Aqueous, and Dual Solvent Extracts of Mushroom Ganoderma lucidum: Genomic and Morphological Analysis. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39766499 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37048331
GET https://conductscience.org/api/papers/v1/37048331/references?page=2